001067.KS

JW Pharmaceutical Corporation [001067.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

001067.KS Stock Summary

In the News

001067.KS Financial details

Company Rating
Buy
Market Cap
757.02B
Income
33.42B
Revenue
750.02B
Book val./share
-
Cash/share
-
Dividend
392.16
Dividend %
0.63%
Employees
1.2K
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
60.33
Forward P/E
-
PEG
31.38
P/S
1.1
P/B
6.19
P/C
-
P/FCF
27.9
Quick Ratio
-
Current Ratio
1.16
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.54K
EPS next Y
-
EPS next Q
-
EPS this Y
14.14%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
7.96%
Revenue Q/Q
12.11%
EPS Q/Q
-227.3%
-
-
-
-
SMA20
-0.42%
SMA50
-0.9%
SMA100
-0.88%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
10%
ROC
0.28%
Gross Margin
45%
Oper. Margin
13%
Profit Margin
3%
Payout
-
Shs Outstand
12.45M
Shs Float
6.4M
-
-
-
-
Target Price
-
52W Range
52254.902-65196.08
52W High
-7.66%
52W Low
+15.21%
RSI
39.18
Rel Volume
0.14
Avg Volume
73
Volume
10
Perf Week
-1.31%
Perf Month
-1.31%
Perf Quarter
-
Perf Half Y
-6.25%
-
-
-
-
Beta
0.597
-
-
Volatility
253.14%, 372.45%
Prev Close
-0.99%
Price
60200
Change
-0.99%

001067.KS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
21.44K22.21K24.95K27.73K0
Net income per share
-1.06K-619.73-59.281.29K0
Operating cash flow per share
2.33K2.56K745.412.3K0
Free cash flow per share
1.78K1.95K214.791.8K0
Cash per share
192.462.24K2.7K6.06K0
Book value per share
9.65K8.42K8.27K9.74K0
Tangible book value per share
8.75K7.7K6.87K8.49K0
Share holders equity per share
9.65K8.42K8.27K9.74K0
Interest debt per share
8.34K7.7K10.38K8.87K0
Market cap
877.34B1250.52B1400.16B1524.56B0
Enterprise value
1023B1422.29B1611.94B1700.2B0
P/E ratio
-34.71-81.86-971.3647.80
Price to sales ratio
1.722.282.312.230
POCF ratio
15.819.8377.2526.860
PFCF ratio
20.6826.04268.1134.330
P/B Ratio
3.816.036.966.340
PTB ratio
3.816.036.966.340
EV to sales
22.62.662.480
Enterprise value over EBITDA
-411.7893.534.0220.60
EV to operating cash flow
18.4222.5688.9429.950
EV to free cash flow
24.1129.62308.6638.280
Earnings yield
-0.03-0.0100.020
Free cash flow yield
0.050.0400.030
Debt to equity
0.820.881.220.870
Debt to assets
0.330.330.390.330
Net debt to EBITDA
-58.6311.294.472.130
Current ratio
1.211.281.31.120
Interest coverage
-1.69-0.724.256.710
Income quality
-2.2-4.13-12.571.90
Dividend Yield
0.010.010.0100
Payout ratio
-0.27-0.46-4.960.230
Sales general and administrative to revenue
0.080.120.140.130
Research and developement to revenue
0.050.040.030.050
Intangibles to total assets
0.040.030.030.030
Capex to operating cash flow
-0.24-0.24-0.71-0.220
Capex to revenue
-0.03-0.03-0.02-0.020
Capex to depreciation
-0.64-0.73-0.8-0.730
Stock based compensation to revenue
00000
Graham number
15.17K10.83K3.32K16.83K0
ROIC
-0.03-0.0200.090.26
Return on tangible assets
-0.05-0.0300.050.05
Graham Net
-6.35K-5.52K-7.52K-3.04K0
Working capital
57.07B64.58B83.77B45.33B0
Tangible asset value
208.7B189.8B167.07B209.49B639.21B
Net current asset value
-8.06B-42.29B-78.06B23.24B0
Invested capital
0.820.881.220.870
Average receivables
211.91B160.88B162.79B177.49B81.07B
Average payables
44.78B46.49B49.76B67.28B41.45B
Average inventory
95.9B95.82B101.86B107.1B55.83B
Days sales outstanding
134.9288.52116.0486.480
Days payables outstanding
46.9947.2650.6476.340
Days of inventory on hand
94.2699.88100.54102.820
Receivables turnover
2.714.123.154.220
Payables turnover
7.777.727.214.780
Inventory turnover
3.873.653.633.550
ROE
-0.11-0.07-0.010.130.13
Capex per share
-549.11-610.14-530.62-500.520

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
7.83K7.18K7.7K8.01K0
Net income per share
528.15643597.45-779.230
Operating cash flow per share
953.2810.31675.711.56K0
Free cash flow per share
837.53-590.42326.321.24K0
Cash per share
6.06K5.62K2.55K3.49K0
Book value per share
9.74K10.29K10.88K10.64K0
Tangible book value per share
8.49K8.76K9.84K9.47K0
Share holders equity per share
9.74K10.29K10.88K10.64K0
Interest debt per share
8.56K11.63K9.46K9.35K0
Market cap
1524.56B1396.71B1420.38B1419.67B0
Enterprise value
1700.2B1654.57B1628.77B1598.26B0
P/E ratio
29.2422.4924.61-19.820
Price to sales ratio
7.898.067.647.710
POCF ratio
64.85.61K87.0539.480
PFCF ratio
73.76-97.97180.2749.960
P/B Ratio
6.345.625.415.810
PTB ratio
6.345.625.415.810
EV to sales
8.89.548.768.680
Enterprise value over EBITDA
54.7521.8419.4819.50
EV to operating cash flow
72.276.65K99.8344.450
EV to free cash flow
82.26-116.06206.7156.240
Earnings yield
0.010.010.01-0.010
Free cash flow yield
0.01-0.010.010.020
Debt to equity
0.871.130.850.870
Debt to assets
0.330.420.350.320
Net debt to EBITDA
5.663.42.492.180
Current ratio
1.121.081.131.160
Interest coverage
17.57-37.065.087.860
Income quality
2.060.021.02-2.010
Dividend Yield
000.0100
Payout ratio
000.6100
Sales general and administrative to revenue
0.120.320.340.30
Research and developement to revenue
0.060.040.040.050
Intangibles to total assets
0.030.030.040.040
Capex to operating cash flow
-0.12-58.29-0.52-0.210
Capex to revenue
-0.01-0.08-0.05-0.040
Capex to depreciation
-0.7-2.18-1.37-1.60
Stock based compensation to revenue
00000
Graham number
10.76K12.2K12.09K13.66K0
ROIC
0.040.030.030.10.12
Return on tangible assets
0.020.020.02-0.030.03
Graham Net
-3.04K-4.98K-5.45K-6.59K0
Working capital
45.33B31.14B42.44B51.08B0
Tangible asset value
209.49B211.46B237.72B217.68B639.21B
Net current asset value
23.24B-18.59B-26.4B-47.46B0
Invested capital
0.871.130.850.870
Average receivables
159.57B162.35B169.71B178.11B89.67B
Average payables
69.19B71.26B58.41B64.75B36.15B
Average inventory
111.05B115.32B118.81B115.72B56.4B
Days sales outstanding
75.5584.3885.6287.630
Days payables outstanding
71.554.9450.3263.640
Days of inventory on hand
96.3109.68104.3499.30
Receivables turnover
1.191.071.051.030
Payables turnover
1.261.641.791.410
Inventory turnover
0.930.820.860.910
ROE
0.050.060.05-0.070.08
Capex per share
-115.75-600.73-349.4-327.980

001067.KS Frequently Asked Questions

What is JW Pharmaceutical Corporation stock symbol ?

JW Pharmaceutical Corporation is a KR stock and trading under the symbol 001067.KS

What is JW Pharmaceutical Corporation stock quote today ?

JW Pharmaceutical Corporation stock price is $60200 today.

Is JW Pharmaceutical Corporation stock public?

Yes, JW Pharmaceutical Corporation is a publicly traded company.

Something similar